The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
PIPETTE 4R Tau and Alpha-Synuclein PET Tracer Development, 2021San Antonio Ligand Consortium (SALC)
Study Rationale:
The development of alpha-synuclein and 4-repeat tau (4RT) positron-emission tomography (PET) imaging agents would benefit people with Parkinson’s disease (PD), progressive... -
Research Grant, 2021A New Target for Limiting the Spread of Toxic Alpha-Synuclein Aggregation and Preventing Neuronal Degeneration
Study Rationale:
The pathological hallmark of Parkinson’s disease (PD) is the widespread accumulation of cellular inclusions, called Lewy Bodies, composed of clumps of improperly folded alpha... -
Access to Data and Biospecimens, 2021Assessing Inhibition of a Protein of the “Complement System” to Reduce Brain Inflammation and Neuronal Loss in People with Parkinson’s Disease
Study Rationale:
Inflammation contributes to the degeneration of neurons in the brains of people with Parkinson’s disease (PD). One of the molecules involved in this inflammatory... -
Biomarkers, 2021The Development of Novel Probes for Imaging Glucocerebrosidase Activity in Parkinson’s Disease
Study Rationale:
Mutations that disable glucocerebrosidase (GBA), a protein that strips sugars from molecules in the membranes of brain cells, are associated with Parkinson’s disease (PD)... -
Research Grant, 2021Parkinson’s Disease Patient Report of Problems (PD-PROP) Curation
Study Rationale:
What people with Parkinson’s feel and experience about their disease, and how it affects their lives, is of paramount importance to their care and participation in research. The... -
Environmental Risk Factors, 2021Pesticide Exposure, Systems Biology and Parkinson’s Disease
Study Rationale:
Pesticide exposure is among the most consistently and widely reported environmental risk factors for Parkinson’s disease (PD). However, research on specific pesticides in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.